|
Novaccess Global Inc (XSNX) |
|
Novaccess Global Inc
XSNX's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Looking into Novaccess Global Inc growth rates, revenue grew
in II. Quarter 2024 from the same quarter a year ago.
Major Pharmaceutical Preparations industry recorded
deterioration of revenues by -0.28 %
Novaccess Global Inc faced net loss in contrast to the net income a year ago in II. Quarter 2024
• More on XSNX's Growth
|
|
Novaccess Global Inc realized a net loss in trailing twelve months.
Novaccess Global Inc realized cash reduction of $ -0 per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 296.76.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.75.
• More on XSNX's Valuation
|
|
|
|
|
Novaccess Global Inc realized net loss in trailing twelve months.
Novaccess Global Inc realized cash outflow of $ -0per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 296.76.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.75.
• More on XSNX's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2024 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com